 |
Fibronectin (human plasma derived) |
|---|---|
| Trade Name | |
| Orphan Indication | Non-healing corneal ulcers or epithelial defects which have been unresponsive to conventional therapy and the underlying cause has been eliminated |
| USA Market Approval | USA |
| USA Designation Date | 1988-09-05 00:00:00 |
| Sponsor | Melville Biologics, Inc.;310 East 67th Street;New York, New York, 10021 |
